Announcements Trials
Browse Landscape

Phase

Phase 4 4Phase NA 1

Status

Recruiting 5Completed 3Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 2Genitourinary 1

Conditions

Lung Neoplasms 2Urinary Bladder Neoplasms 1Tuberculosis, Pulmonary 1Thoracic Diseases 1Recurrence 1Neoplasm Metastasis 1Intraoral Tumor 1Hypoxia 1Emergence Delirium 1Delirium 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Specimen Handling 482pembrolizumab 454Magnetic Resonance Spectroscopy 419Carboplatin 321Cyclophosphamide 314Biopsy 272Cisplatin 264Radiotherapy 241Paclitaxel 226Gemcitabine 224Bevacizumab 212Nivolumab 189fludarabine 183venetoclax 172Drug Therapy 166Dexamethasone 157Blood Specimen Collection 156Oxaliplatin 154Injections 152Capecitabine 152Fluorouracil 144Docetaxel 143Standard of Care 136Radiosurgery 136Rituximab 125Pemetrexed 115durvalumab 113atezolizumab 110Leucovorin 110Radiation 105

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Propofol × 1 year × Clear all
NCT06330038 2026-04-20

GASTIVA

Samsung Medical Center

Phase 4 Recruiting
5,384 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis, Recurrence

NCT07395596 2026-02-24

Remimazolam for Bronchoscopy in High-Risk Patients

First Affiliated Hospital of Zhejiang University

Phase 4 Recruiting
360 enrolled

Hypoxia, Tuberculosis, Pulmonary

NCT07028593 2026-01-28

CP-MINS

Tongji Hospital

Phase 4 Recruiting
1,058 enrolled
Thoracic

Lung Neoplasms, Thoracic Diseases

NCT06275087 2025-12-24

PSIOS

Clinical Hospital Centre Zagreb

Phase NA Recruiting
42 enrolled

Intraoral Tumor

NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Peking University First Hospital

Phase 4 Recruiting
1,128 enrolled
Genitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡